Beyond Medical Cash Per Share vs. Market Capitalization
DOCKF Stock | USD 0.02 0 22.70% |
Cash Per Share | First Reported 2010-12-31 | Previous Quarter 0.00750702 | Current Value 0.007132 | Quarterly Volatility 8.81429023 |
For Beyond Medical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Beyond Medical to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Beyond Medical Technologies utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Beyond Medical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Beyond Medical Technologies over time as well as its relative position and ranking within its peers.
Beyond |
Is Industrial Machinery & Supplies & Components space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Beyond Medical. If investors know Beyond will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Beyond Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.04) | Revenue Per Share (0) | Quarterly Revenue Growth (0.92) | Return On Assets (2.19) | Return On Equity (1.89) |
The market value of Beyond Medical Techn is measured differently than its book value, which is the value of Beyond that is recorded on the company's balance sheet. Investors also form their own opinion of Beyond Medical's value that differs from its market value or its book value, called intrinsic value, which is Beyond Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Beyond Medical's market value can be influenced by many factors that don't directly affect Beyond Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Beyond Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Beyond Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Beyond Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Beyond Medical Techn Market Capitalization vs. Cash Per Share Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Beyond Medical's current stock value. Our valuation model uses many indicators to compare Beyond Medical value to that of its competitors to determine the firm's financial worth. Beyond Medical Technologies is one of the top stocks in cash per share category among its peers. It also is one of the top stocks in market capitalization category among its peers creating about 16,838,000 of Market Capitalization per Cash Per Share. At this time, Beyond Medical's Cash Per Share is most likely to drop in the upcoming years. Comparative valuation analysis is a catch-all technique that is used if you cannot value Beyond Medical by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Beyond Market Capitalization vs. Cash Per Share
Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Beyond Medical |
| = | 0.01 X |
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Beyond Medical |
| = | 168.38 K |
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
Beyond Market Capitalization vs Competition
Beyond Medical Technologies is one of the top stocks in market capitalization category among its peers. Market capitalization of Industrials industry is currently estimated at about 169.29 Billion. Beyond Medical adds roughly 168,380 in market capitalization claiming only tiny portion of equities under Industrials industry.
Beyond Medical Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Beyond Medical, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Beyond Medical will eventually generate negative long term returns. The profitability progress is the general direction of Beyond Medical's change in net profit over the period of time. It can combine multiple indicators of Beyond Medical, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last Reported | Projected for Next Year | ||
Net Loss | -2.6 M | -2.8 M | |
Net Interest Income | -9.4 K | -8.9 K | |
Interest Income | 6.3 K | 6 K | |
Operating Income | -548.5 K | -575.9 K | |
Net Loss | -552 K | -579.6 K | |
Income Before Tax | -552 K | -579.6 K | |
Total Other Income Expense Net | -3.5 K | -3.7 K | |
Net Loss | -596 K | -625.8 K | |
Change To Netincome | 944 K | 896.8 K | |
Net Loss | (0.07) | (0.07) | |
Income Quality | 0.95 | 0.63 | |
Net Income Per E B T | 1.08 | 2.04 |
Beyond Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Beyond Medical. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Beyond Medical position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Beyond Medical's important profitability drivers and their relationship over time.
Use Beyond Medical in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Beyond Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Beyond Medical will appreciate offsetting losses from the drop in the long position's value.Beyond Medical Pair Trading
Beyond Medical Technologies Pair Trading Analysis
The ability to find closely correlated positions to Beyond Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Beyond Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Beyond Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Beyond Medical Technologies to buy it.
The correlation of Beyond Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Beyond Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Beyond Medical Techn moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Beyond Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Beyond Medical position
In addition to having Beyond Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Market Neutral Funds Thematic Idea Now
Market Neutral Funds
Funds or Etfs that invest in both long and short positions of different entities to enhance returns from broad market movements over time. The Market Neutral Funds theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Market Neutral Funds Theme or any other thematic opportunities.
View All Next | Launch |
Check out Investing Opportunities. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
To fully project Beyond Medical's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Beyond Medical Techn at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Beyond Medical's income statement, its balance sheet, and the statement of cash flows.